N. prodotti: 0
Totale ordine: € 0,00
Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,632
Online ISSN 1827-191X
Van Der Heyden J. 1, Van Werkum J. 1, 2, Hackeng C. M. 2, 3, Kelder J. C. 1, 2, Breet N. J. 1, 2, Deneer V. H. M. 2, 4, Ackerstaff R. G. A. 5, Tromp S. C. 5, De Vries J. P. P. M. 6, Vos J. A. 7, Suttorp M. J. 1, Elsenberg E. H. A. 1, 2, Van Neerven D. 1, 2, Schonewille W. J. 8, Wolters F. 1, 2, Ten Berg J. M. 1, 2
1 Department of Interventional Cardiology, St Antonius Hospital Nieuwegein, The Netherlands;
2 St Antonius Centre for Platelet Function Research, St Antonius Hospital Nieuwegein, The Netherlands;
3 Department of Biochemistry, St Antonius Hospital Nieuwegein, The Netherlands;
4 Department of Clinical Pharmacy, St Antonius Hospital Nieuwegein, The Netherlands;
5 Department of Clinical Neurophysiology, St Antonius Hospital Nieuwegein, The Netherlands;
6 Department of Vascular Surgery, St Antonius Hospital Nieuwegein, The Netherlands;
7 Department of Interventional Radiology, St Antonius Hospital Nieuwegein, The Netherlands;
8 Department of Neurology, St Antonius Hospital Nieuwegein, The Netherlands
Aim: The aim of this study was to compare the effects of 300 mg or 600 mg clopidogrel loading dose, prior to carotid artery stenting (CAS) on the number of transcranial Doppler (TCD)-detected microembolic signals (MES) and to investigate the relationship between the magnitude of platelet reactivity and MES.
Methods: In this prospective randomized, double-blind study, 35 consecutive asymptomatic patients (17.1% females), scheduled for CAS and cardiac surgery were included. The primary endpoint was the number of TCD-detected MES. The secondary endpoints were the absolute magnitude of on-treatment platelet reactivity and the adverse cerebral events. Negative binomial regression to find predictors for sum of single emboli, the student’s t-test to assess the association between platelet function tests and randomized dose of 300 mg or 600 mg clopidogrel, and the R2 calculation for the assessment of the association between platelet function tests and embolic load, were used.
Results: No statistically significant difference in the number of TCD-detected MES, in the sum of all the single emboli or showers and platelet aggregation measurements between the two groups was observed (aggregometry: 21.7±18.3 versus 23±18%, P=0.8499 and 45.8±17.5 versus 46.5±14.5%, P=0.9003) (verifyNow P2Y12 assay: 231±93 PRU versus 222±86 PRU, P=0.7704). In one patient a transient ischemic attack occurred.
Conclusion: A loading dose of 300 mg of clopidogrel in combination with aspirin is as effective as 600 mg of clopidogrel in achieving adequate platelet inhibition and preventing periprocedural events in asymptomatic patients undergoing CAS prior to cardiac surgery.